Developing advanced machine learning models for understanding diseases and drug responses
Robust, Generalizable, and Fair Machine Learning Models for Biomedicine
This study is all about using smart computer programs to look at different kinds of health information, like genetics and personal details, to better understand diseases and predict how well patients will respond to treatments, making it easier for doctors to help you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10897982 on NIH RePORTER |
What this research studies
This research focuses on creating robust machine learning models that can analyze various types of biomedical data, such as genetic information and patient characteristics. By integrating these data sources, the research aims to uncover the underlying mechanisms of diseases and improve predictions regarding how patients will respond to different medications. The approach combines advanced causal inference techniques with machine learning to enhance the accuracy and fairness of predictions. Over the next five years, the team will work on developing these innovative computational methods to transform biomedical data into actionable insights.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with various diseases who are undergoing treatment and may benefit from personalized medication strategies.
Not a fit: Patients with conditions that are not well-represented in the biomedical data being analyzed may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of drug responses and better understanding of disease mechanisms, ultimately improving patient care.
How similar studies have performed: Other research has shown success in using machine learning for biomedical applications, but this approach is innovative in its integration of causal inference techniques.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Yu, Kun-Hsing — Harvard Medical School
- Study coordinator: Yu, Kun-Hsing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.